Duration of Continuous Positive Airway Pressure and Pulmonary Function Testing in Preterm Infants
Completed · Not applicable
Conditions studied: Respiratory Distress Syndrome, Bronchopulmonary Dysplasia
In brief
The primary aim of this study is to quantify and compare changes in lung volumes (as measured by functional residual capacity) in premature infants stable on continuous positive airway pressure (CPAP), and then randomized to two additional weeks of CPAP and room air versus room air alone. We hypothesize that infants randomized to additional CPAP will demonstrate an increased functional residual capacity (at the end of the two week study period and prior to discharge) compared to those randomized to room air.
Key facts
- Study ID
- NCT02249143
- Run by
- Oregon Health and Science University
- People needed
- 50
- Starts
- 2014-09-01
- Expected to finish
- 2017-09-01
- Last updated by the study team
- 2019-08-29
Who can join
Age: any, up to 1. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Gestational age at birth <33 weeks
- Required CPAP for a minimum of 24 hours for respiratory distress
- Patient on CPAP and room air at time of randomization
You may not qualify if…
- Complex congenital heart disease other than patent ductus arteriosus or atrial septal defect
- Major malformations or chromosomal anomalies
- Multiple gestation greater than twins
- Culture proven sepsis or unstable at time of randomization
Where it is running
- Oregon Health & Science University — Portland, Oregon, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.